美国 · SEC FORM 4
Biohaven Ltd.
BHVN · NYSE · CIK 0001935979 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
0 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
当前 180 天窗口内没有 Form 4 交易事件。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-17 · Clark George C..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -18.0%
- 3M
- -19.8%
- 6M
- +31.3%
- 12M
- —
波动率与流动性
- 波动率
- 91.8%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- -1418.8%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-04 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 19,053,695
- 上期报告
- 20,449,005
- 日均成交量
- 2,964,176
- 回补天数
- 6.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-11-17 | Clark George C. | 买入 (P) | Common Shares | 17,000 | USD 8.52 | USD 144,840 | SEC 申报 ↗ |
| 2025-11-13 | Coric Vlad | 买入 (P) | Common Shares | 333,333 | USD 7.50 | USD 2,499,998 | SEC 申报 ↗ |
| 2025-11-13 | CHILDS JOHN W | 买入 (P) | Common Shares | 3,333,333 | USD 7.50 | USD 24,999,998 | SEC 申报 ↗ |
| 2025-11-13 | Bailey Gregory | 买入 (P) | Common Shares | 400,000 | USD 7.50 | USD 3,000,000 | SEC 申报 ↗ |
| 2025-03-04 | CHILDS JOHN W | 买入 (P) | Common Shares | 28,400 | USD 30.43 | USD 864,212 | SEC 申报 ↗ |
| 2025-03-04 | CHILDS JOHN W | 买入 (P) | Common Shares | 29,300 | USD 30.44 | USD 891,889 | SEC 申报 ↗ |
| 2024-12-30 | CHILDS JOHN W | 买入 (P) | Common Shares | 29,000 | USD 35.94 | USD 1,042,260 | SEC 申报 ↗ |
| 2024-10-02 | Coric Vlad | 买入 (P) | Common Shares | 21,052 | USD 47.50 | USD 999,970 | SEC 申报 ↗ |
| 2024-10-02 | CHILDS JOHN W | 买入 (P) | Common Shares | 21,052 | USD 47.50 | USD 999,970 | SEC 申报 ↗ |
| 2024-09-24 | Bailey Gregory | 买入 (P) | Common Shares | 5,000 | USD 44.19 | USD 220,950 | SEC 申报 ↗ |
| 2024-07-18 | CHILDS JOHN W | 买入 (P) | Common Shares | 28,400 | USD 35.67 | USD 1,013,028 | SEC 申报 ↗ |
| 2024-06-17 | Car Bruce | 买入 (P) | Common Shares | 30,000 | USD 33.58 | USD 1,007,400 | SEC 申报 ↗ |
| 2024-05-30 | CHILDS JOHN W | 买入 (P) | Common Shares | 28,000 | USD 35.58 | USD 996,240 | SEC 申报 ↗ |
| 2024-05-13 | Bailey Gregory | 买入 (P) | Common Shares | 15,000 | USD 34.19 | USD 512,850 | SEC 申报 ↗ |
| 2024-05-13 | CHILDS JOHN W | 买入 (P) | Common Shares | 28,500 | USD 35.17 | USD 1,002,345 | SEC 申报 ↗ |
Form 4 申报证据
15 transaction lines in the latest 365-day window; 174 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-17 | Mehta Kishan | 赠与 (G) | Common Shares | 17,342 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Gentile Kimberly | 期权行权／转换 (M) | Common Shares | 3,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Gentile Kimberly | 代扣税 (F) | Common Shares | 1,956 | USD 9.93 | USD 19,423 | SEC 申报 ↗ |
展开近期 Form 4 证据 (15 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-03-17 | Mehta Kishan | 赠与 (G) | Common Shares | 17,342 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Gentile Kimberly | 期权行权／转换 (M) | Common Shares | 3,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Gentile Kimberly | 代扣税 (F) | Common Shares | 1,956 | USD 9.93 | USD 19,423 | SEC 申报 ↗ |
| 2026-01-05 | Coric Vlad | 期权行权／转换 (M) | Common Shares | 14,250 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Coric Vlad | 代扣税 (F) | Common Shares | 7,430 | USD 9.93 | USD 73,780 | SEC 申报 ↗ |
| 2026-01-05 | Clark George C. | 期权行权／转换 (M) | Common Shares | 2,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Clark George C. | 代扣税 (F) | Common Shares | 1,117 | USD 9.93 | USD 11,092 | SEC 申报 ↗ |
| 2026-01-05 | Car Bruce | 期权行权／转换 (M) | Common Shares | 4,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Car Bruce | 代扣税 (F) | Common Shares | 2,381 | USD 9.93 | USD 23,643 | SEC 申报 ↗ |
| 2026-01-05 | Buten Matthew | 期权行权／转换 (M) | Common Shares | 4,250 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Buten Matthew | 代扣税 (F) | Common Shares | 2,594 | USD 9.93 | USD 25,758 | SEC 申报 ↗ |
| 2025-11-17 | Clark George C. | 买入 (P) | Common Shares | 17,000 | USD 8.52 | USD 144,840 | SEC 申报 ↗ |
| 2025-11-13 | Coric Vlad | 买入 (P) | Common Shares | 333,333 | USD 7.50 | USD 2,499,998 | SEC 申报 ↗ |
| 2025-11-13 | CHILDS JOHN W | 买入 (P) | Common Shares | 3,333,333 | USD 7.50 | USD 24,999,998 | SEC 申报 ↗ |
| 2025-11-13 | Bailey Gregory | 买入 (P) | Common Shares | 400,000 | USD 7.50 | USD 3,000,000 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BHVN |
| CIK | 0001935979 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 174 transaction lines from 2022-10-03 to 2026-03-17 53 P purchase lines · 1 S sale lines · 120 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.